Sepsis is a critical complication caused due to issues in the functioning of a human system that results in people becoming susceptible to viral, parasitic, bacterial, fungal, and other types of infections. These complications can also arise due to chronic disease, liver, kidney, or cancer diseases which may lead to the death of a patient.
Sepsis diagnostics methods are evolving with advancements in medical technologies and can be used for diagnosing septic shock. Various governments across the globe started initiatives and awareness programs to educate people regarding the diagnosis. The treatment for sepsis depends on factors such as site and cause of infections. Early diagnosis for symptoms of sepsis can be done by visiting a hospital or clinic.
Key factors driving significant growth for the global sepsis diagnostics market include growing healthcare awareness among the global population, increasing prevalence of antibiotic-resistant bacterial strains, rising healthcare expenditure, and growing aging population. In addition to this, an increase in the number of surgical procedures performed across the globe coupled with rising regulatory approval for technologically advanced medical solutions for severe disease conditions is further contributing to the exponential growth of the market.
Moreover, the rapidly growing healthcare sector and the growing usage of advanced data analytics tools are also among the major driving factors for the sepsis diagnostics market. Furthermore, increasing investment in comprehensive R&D activities that include advanced approaches for treating chronic infections is creating new growth avenues for the market players.
- Assays and reagents progressing as the leading revenue generator segment, owing to the rising adoption of assays in the sepsis diagnosis, increasing investments for developing standard diagnostic methods, and rising product approvals globally.
- Laboratory testing is emerged as the fastest-growing segment in the global sepsis diagnostics market and is projected to continue the same trend in the coming years. An increasing number of blood culture tests performed in laboratory settings and the availability of advanced laboratory instruments contribute to the growth of the segment.
- The bacterial sepsis segment holds the largest share in the market and is predicted to grow as the major revenue generator during the forecast period. Increasing cases of bacteria caused bloodstream infections, pneumonia, and urinary tract infection are responsible for the highest share of the segment.
- Some of the leading players operating in the global sepsis diagnostics market are T2 Biosystems, Inc., Abbott Laboratories, Inc., BioMérieux SA, Cepheid, Roche Diagnostics Limited, Bruker Corporation, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Dickinson and Company, Nanosphere, Inc., and among others.
As per the geographical scenario, North America continuously dominating the global market for sepsis diagnostics in terms of value, on account of rising incidents of chronic diseases, growing demand for better healthcare facilities, high per capita healthcare expenditure, and increasing adoption of advanced diagnostic techniques. In addition to this, increasing cases of hospital-acquired infection in the region is further supporting the regional market growth.
On the other side, Asia Pacific is anticipated to grow with the highest CAGR over the forecast period. Rising geriatric population in the region along with the increasing prevalence of diabetes and cancer in major countries such as India, China, and Australia. However, the unavailability of a skilled workforce and lack of awareness among some sections in the region are hampering the growth of the regional market.
Deep-dive Insights on Sepsis Diagnostics Market by Polaris Market Research: https://www.polarismarketresearch.com/industry-analysis/global-sepsis-diagnostics-market